KARIYA (Japan) - DENSO Corporation to acquire 5 percent stake in A&D Company, Limited, which manufactures and distributes medical, healthcare, testing, and measuring devices.

"The goal of this investment is for the two companies to jointly develop more competitive products and improve sales capability by using A&D's proprietary technologies and sales network in the areas of medicine, healthcare, testing, and measurement, and DENSO's sensing technologies cultivated through R&D on automotive components," said Koji Kobayashi, DENSO's executive vice president.

Especially in the area of medical and healthcare, A&D manufactures and distributes blood pressure monitors, weighing scales, and other medical and healthcare devices to medical institutions and households. For DENSO, A&D is one of the investment partners to UNEX Corporation, a medical and healthcare equipment manufacturer.

DENSO considers medical and health as one of the important fields in the new business area, and will collaborate with A&D to develop and offer new products to contribute to people’s healthier lives.

Profile of A&D Company, Limited

1. Establishmen	May 1977
2. Location	3-23-14, Higashi-Ikebukuro, Toshima-ku, Tokyo
3. Sales	Consolidated sales of 30.967 billion yen (unconsolidated sales of 22.375 billion yen)
4. Business description	Manufacturing and sales of medical, healthcare, testing, and measuring devices
5. Capital	6.388 billion yen
6. Employees	3,058
7. Website	http://www.aandd.jp/

DENSO Corporation, headquartered in Kariya, Aichi prefecture, Japan, is a leading global automotive supplier of advanced technology, systems and components in the areas of thermal, powertrain control, electronics and information and safety. Its customers include all the world's major carmakers. Worldwide, the company has more than 200 subsidiaries and affiliates in 35 countries and regions (including Japan) and employs approximately 120,000 people. Consolidated global sales for the fiscal year ending March 31, 2012, totaled US$38.4 billion. Last fiscal year, DENSO spent 9.5 percent of its global consolidated sales on research and development. DENSO common stock is traded on the Tokyo and Nagoya stock exchanges. For more information, go to www.denso.com/global/en/, or visit our media website at www.densomediacenter.com .